Announcements Trials

Browse Landscape

Status

Terminated 1 Completed 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Rectal Neoplasms 2 Colonic Neoplasms 2 Breast Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 1 Prostatic Neoplasms 1 Ovarian Neoplasms 1 Neoplasm Metastasis 1 Head and Neck Neoplasms 1 Colorectal Neoplasms 1 Anus Neoplasms 1

Interventions

pembrolizumab 29 Capecitabine 24 Bevacizumab 23 Cyclophosphamide 22 Gemcitabine 21 Paclitaxel 20 Nivolumab 19 Fluorouracil 19 Docetaxel 18 aldesleukin 17 Leucovorin 17 Irinotecan 17 Oxaliplatin 15 Interleukin-2 14 Radiosurgery 13 Cisplatin 13 Cetuximab 13 fludarabine 12 Carboplatin 12 Albumin-Bound Paclitaxel 11 fludarabine phosphate 10 Ipilimumab 10 Drug Therapy 10 Doxorubicin 10 Sunitinib 9 Radiotherapy 9 Everolimus 9 130-nm albumin-bound paclitaxel 9 Trastuzumab 8 Temozolomide 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Neoplasm Metastasis × Genetic Testing × Clear all

NCT03503097 2025-10-01

GENTleMEN

University of Washington

Neoplasm Metastasis, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡